Back to
TD ASSET MANAGEMENT INC
AXSM
Showing 6 of 18 quarters
Position history for
TD ASSET MANAGEMENT INC's holdings in AXSOME THERAPEUTICS INC.
Yes. TD Asset Management holds 24,204 shares of AXSM (Axsome Therapeutics), worth $5.9M, as of its Q2 2026 13F filing. It reduced the position by 2,928 shares (-10.8%) from Q1 2026. TD Asset Management has held AXSM since Q1 2025, across 6 quarterly 13F filings.
Current Value
$5.9M
Current Shares
24,204
Total Value Change
+$4.9M
Total Shares Change
+15,220
Quarter-by-Quarter History